Related Experiment Video
Updated: Apr 20, 2026

06:59
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
148
Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma
Hanna Pitkänen1, Annukka Jouppila1, Marie-Christine Mowinckel2
1Helsinki University Central Hospital Research Institute, Helsinki, Finland.
Thrombosis Research
|December 4, 2014
Summary
Solvent/detergent (S/D)-treated plasma shows increased thrombin generation and fibrinolysis due to reduced functional protein S. Tranexamic acid may help manage S/D-treated plasma
Area of Science:
- Hematology
- Transfusion Medicine
- Biochemistry
Background:
- Solvent/detergent (S/D)-treated plasma is an alternative to fresh frozen-plasma (FFP) for severe bleeds.
- Investigating compositional changes in S/D-treated plasma is crucial for its clinical application.
Purpose of the Study:
- To explore compositional modifications in S/D-treated plasma.
- To assess the impact of these modifications on hemostatic and fibrinolytic properties.
Main Methods:
- Comparison of S/D-treated plasma and FFP for procoagulant microparticles and coagulation factors/inhibitors.
- Evaluation of PT, APTT, thrombin generation, and thromboelastography.
Main Results:
- S/D-treated plasma lacks procoagulant microparticles; coagulation factors are generally normal.
- Reduced intact functional protein S (12-14%) in S/D-treated plasma leads to increased thrombin generation.
- Enhanced fibrinolysis observed, with shortened clot lysis times, manageable with tranexamic acid.
Conclusions:
- S/D-treatment may induce a procoagulant phenotype due to reduced functional protein S.
- The clinical significance of increased fibrinolysis and potential benefits in anticoagulant deficiencies require further study.
- Tranexamic acid co-administration is beneficial for controlling enhanced fibrinolysis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Clot Retraction and Fibrinolysis
10.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.6K
Venous Thrombosis III: Interprofessional Care
475
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
475
Extrinsic and Intrinsic Pathways of Hemostasis
16.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
16.2K

